Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M31.5Revenue $M0Net Margin (%)0Z-Score-6.2
Enterprise Value $M7.0EPS $-1.2Operating Margin %0F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book1.410-y EBITDA Growth Rate %-16.1Quick Ratio15.4Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %-32.2Current Ratio15.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-44.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-53.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M22.7ROI % (ttm)-70.8Gross Margin Increase y-yN

Gurus Latest Trades with BIOD

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIODDavid Swensen 2010-12-31 Sold Out $6.44 - $19.08
($10.24)
$ 1.39-86%Sold Out0
BIODDavid Swensen 2009-12-31 Buy 11.73%$14.16 - $21.04
($16.88)
$ 1.39-92%New holding, 903400 sh.903,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIOD is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BIOD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LIEBERMAN IRADirector 2013-12-20Buy10,800$2.29-39.3view
Pereira Brian JGDirector 2013-12-20Sell4,734$2.26-38.5view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-12-07Sell12,256$2.8-50.36view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-11-02Sell3,500$2.81-50.53view
Krasner Alan SethChief Medical Officer 2012-11-02Sell3,500$2.81-50.53view
DESOUZA ERROL BCEO 2012-09-20Buy10,000$3.34-58.38view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-03-13Sell2,096$2.36-41.1view
Pereira Brian JGDirector 2011-12-16Sell3,750$2.6-46.54view
Steiner SolomonDirector 2011-09-26Sell32,695$4.36-68.12view
Steiner SolomonDirector 2011-09-21Sell79,129$4.72-70.55view

Press Releases about BIOD :

    Quarterly/Annual Reports about BIOD:

    News about BIOD:

    Articles On GuruFocus.com
    cooldecency99 note on BIOD May 01 2010 
    Biodel Reports Third Quarter Fiscal Year 2009 Financial Results Aug 07 2009 
    Biodel to Report Third Quarter Fiscal Year 2009 Results on August 7, 2009 Aug 03 2009 
    Biodel Reports First Quarter Fiscal Year 2009 Financial Results and Clinical Update Feb 05 2009 
    Biodel to Report First Quarter Fiscal Year 2009 Results and Top Line Results of Bioequivalence Study Jan 30 2009 
    Biodel Inc. Reports Fourth Quarter and Fiscal Year 2008 Financial Results Dec 10 2008 


    More From Other Websites
    BIODEL INC Files SEC form 10-K, Annual Report Dec 19 2014
    Nasdaq stocks posting largest volume increases Dec 18 2014
    BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition Dec 17 2014
    Biodel Reports Fourth Quarter Fiscal Year 2014 Financial Results Dec 17 2014
    Q4 2014 Biodel Inc Earnings Release - 4:00 pm ET Dec 17 2014
    Biodel to Report Fourth Quarter Fiscal Year 2014 Financial Results on December 17, 2014 Dec 10 2014
    Cempra (CEMP) in Focus: Stock Rises 11.4% in Session Dec 09 2014
    Biodel Initiates Clinical Proof of Concept Study in Glucagon Emergency Management Program Dec 04 2014
    Biodel Successfully Defends Ultra-Rapid-Acting Insulin Formulation Technology in European Patent... Dec 01 2014
    Biodel Successfully Defends Ultra-Rapid-Acting Insulin Formulation Technology in European Patent... Nov 18 2014
    Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 6.4% Nov 18 2014
    Endocyte, Inc. (ECYT) in Focus: Stock Surges 18% Nov 07 2014
    Synergy Pharmaceuticals, Inc. (SGYP) Surges: Stock Rises 10% Oct 30 2014
    BIODEL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Oct 27 2014
    Biodel Announces Data Presentations at the 50th Annual Meeting of the EASD Sep 15 2014
    BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Aug 27 2014
    Biodel Appoints Gary G. Gemignani as Chief Financial Officer Aug 25 2014
    BIODEL INC Financials Aug 22 2014
    Biodel Q3 Loss Narrower than Expected, Gives Pipeline Update Aug 14 2014
    BIODEL INC Files SEC form 10-Q, Quarterly Report Aug 13 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK